Two-year clinical outcomes of resorbable magnesium scaffold versus conventional drug-eluting stents in ST-segment elevation myocardial infarction: A propensity score matching analysis

Hellenic J Cardiol. 2024 Jul-Aug:78:84-86. doi: 10.1016/j.hjc.2023.12.004. Epub 2023 Dec 21.

¹ Department of Cardiology, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
² Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
³ Department of Cardiology, University Hospital of Lausanne, Lausanne, Switzerland.
⁴ CHU UCL Namur, Site de Mont Godinne, Université Catholique de Louvain, Belgium.
⁵ Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZB), Department of Cardiology, Brussels, Belgium.
⁶ CHR Citadelle, Liège, Belgium.
⁷ Hôpital Cochin, Assistance Publique des Hôpitaux de Paris, Paris, France.
⁸ Research Center for Statistics, Geneva School of Economics and Management, University of Geneva, Switzerland.
⁹ Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland.
¹⁰ Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
¹¹ Department of Cardiology, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: quentin.dehemptinne@stpierre-bru.be.

No abstract available

Keywords: Magmaris; STEMI; primary PCI; resorbable magnesium scaffold.

Publication types